Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Small Plaque Psoriasis”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05728489
What this trial is testing

Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 64
Testing effectiveness (Phase 2)Study completedNCT03832738
What this trial is testing

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasisSkin Diseases
Akros Pharma Inc. 152
Very early researchEnded earlyNCT01317017
What this trial is testing

Cell Responses to IFN-gamma

Who this might be right for
Plaque Psoriasis
Rockefeller University 2
Large-scale testing (Phase 3)Study completedNCT03777436
What this trial is testing

An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis

Who this might be right for
Psoriasis
Amgen 289
Testing effectiveness (Phase 2)Study completedNCT01634087
What this trial is testing

Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Incyte Corporation 50
Large-scale testing (Phase 3)Study completedNCT00141921
What this trial is testing

Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

Who this might be right for
Pediatric Plaque Psoriasis
Amgen 182
Early research (Phase 1)Ended earlyNCT01948271
What this trial is testing

Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 3
Post-approval studies (Phase 4)Study completedNCT03403036
What this trial is testing

Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies

Who this might be right for
Psoriasis
Icahn School of Medicine at Mount Sinai 39
Post-approval studies (Phase 4)Study completedNCT03848871
What this trial is testing

The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Derm Research, PLLC 20
Post-approval studies (Phase 4)Study completedNCT00436540
What this trial is testing

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

Who this might be right for
Psoriasis
Galderma R&D 78
Not applicableStudy completedNCT01084668
What this trial is testing

Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs

Who this might be right for
Psoriasis Chronic
Abbott 46
Testing effectiveness (Phase 2)Study completedNCT03614078
What this trial is testing

PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis VulgarisPlaque Psoriasis
PRCL Research Inc. 92
Large-scale testing (Phase 3)Active Not RecruitingNCT06095115
What this trial is testing

JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 684
Large-scale testing (Phase 3)Study completedNCT04785326
What this trial is testing

Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Dong-A ST Co., Ltd. 598
Testing effectiveness (Phase 2)Study completedNCT05375955
What this trial is testing

Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 263
Testing effectiveness (Phase 2)Study completedNCT03837743
What this trial is testing

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Durect 25
Early research (Phase 1)Study completedNCT01563068
What this trial is testing

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 18
Not applicableStudy completedNCT04398732
What this trial is testing

Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Pfizer 486
Post-approval studies (Phase 4)Study completedNCT00658606
What this trial is testing

Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects

Who this might be right for
Plaque Psoriasis
Astellas Pharma Inc 98
Early research (Phase 1)Study completedNCT00871598
What this trial is testing

BTT1023 in Psoriasis

Who this might be right for
Plaque Psoriasis
Biotie Therapies Corp. 26
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation